Iradimed Corporation (NASDAQ:IRMD) Short Interest Update

Iradimed Corporation (NASDAQ:IRMD) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 124,100 shares, a growth of 18.2% from the December 15th total of 105,000 shares. Based on an average trading volume of 39,400 shares, the days-to-cover ratio is currently 3.1 days. Approximately 1.6% of the shares of the stock are sold short.

Insider Buying and Selling

In related news, CFO John Glenn sold 2,500 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $54.18, for a total transaction of $135,450.00. Following the transaction, the chief financial officer now directly owns 4,383 shares in the company, valued at approximately $237,470.94. The trade was a 36.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 37.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Iradimed

Institutional investors and hedge funds have recently made changes to their positions in the stock. Huntington National Bank raised its stake in shares of Iradimed by 51.3% in the 3rd quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock valued at $75,000 after acquiring an additional 504 shares during the period. Gladius Capital Management LP raised its stake in shares of Iradimed by 126.6% in the 3rd quarter. Gladius Capital Management LP now owns 1,727 shares of the medical equipment provider’s stock valued at $87,000 after acquiring an additional 965 shares during the period. Quantbot Technologies LP raised its stake in shares of Iradimed by 83.0% in the 3rd quarter. Quantbot Technologies LP now owns 2,320 shares of the medical equipment provider’s stock valued at $117,000 after acquiring an additional 1,052 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of Iradimed in the 3rd quarter valued at approximately $126,000. Finally, SG Americas Securities LLC purchased a new stake in Iradimed during the 3rd quarter worth approximately $147,000. 92.34% of the stock is owned by hedge funds and other institutional investors.

Iradimed Stock Up 1.4 %

NASDAQ:IRMD traded up $0.81 on Friday, hitting $59.17. The stock had a trading volume of 50,168 shares, compared to its average volume of 37,022. The stock has a market cap of $749.68 million, a price-to-earnings ratio of 40.53 and a beta of 0.81. The company has a fifty day moving average price of $54.76 and a two-hundred day moving average price of $50.17. Iradimed has a 1-year low of $40.18 and a 1-year high of $59.31.

Iradimed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Friday, November 15th were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend was Friday, November 15th. Iradimed’s dividend payout ratio (DPR) is 41.10%.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.